Skip to main content
Jonathan Kay, MD, Rheumatology, Worcester, MA, UMass Memorial Medical Center

JonathanKayMD(He/Him)

Rheumatology • Worcester, MA

Rheumatoid Arthritis & Related, Spondyloarthropathy, Clinical Pharmacology

Timothy S. & Elaine L. Peterson Chair in Rheumatology and Professor of Medicine and of Population and Quantitative Health Sciences, UMass Chan Medical School

Join to view full profile

Dr. Kay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kay's full profile

Already have an account?

  • Office

    119 Belmont Street
    Rheumatology Center, Memorial Campus
    Worcester, MA 01605
    Phone+1 508-334-6273
    Fax+1 508-334-6038
  • Is this information wrong?

Summary

  • Dr. Jonathan Kay is a rheumatologist in Worcester, MA and is affiliated with UMass Memorial Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 34 years. He specializes in rheumatoid arthritis & related, spondyloarthropathy, and clinical pharmacology and is experienced in ankylosing spondylitis, osteoarthritis, rheumatoid arthritis, polymyalgia rheumatica, and psoriatic arthritis. He has more than 100 publications and over 500 citings.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Rheumatology, 1986 - 1989
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1984 - 1986
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1983 - 1984
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1983
  • Harvard University
    Harvard UniversityBA, Biochemical Sciences, Magna cum laude, 1975 - 1979

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2025
  • PA State Medical License
    PA State Medical License 1984 - 1988
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Master (MACR) American College of Rheumatology, 2023
  • Timothy S. and Elaine L. Peterson Chair in Rheumatology University of Massachusetts Medical School, 2016
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.  
    Hou FF, Boyce J, Chertow GM, Kay J, Owen WF Jr, J Am Soc Nephrol 1998;9:277-83
  • Nonsteroidal anti-inflammatory drugs.  
    Kay J, Weinblatt ME, Medical Update (Brigham and Women’s Hospital).1989; 1(9):1-5
  • Rheumatology Grand Rounds.Musculoskeletal manifestations in ?2-microglobulin amyloidosis: case discussion.  
    Gravallese EM, Baker N, Lester S, Kay J, Owen WF Jr, Arthritis Rheum 1992;35:592-602
  • Join now to see all

Books/Book Chapters

  • Clinical manifestations and diagnosis of Felty's syndrome. 
    Kay JEditors: UpToDate, Basow DS.Waltham, MA
  • Drug therapy in Felty's syndrome. 
    Kay JEditors: UpToDate, Basow DS.Waltham, MA
  • Indications for splenectomy in Felty's syndrome. 
    Kay JEditors: UpToDate, Basow DS.Waltham, MA
  • Join now to see all

Abstracts/Posters

  • Preclinical efficacy of a PDGFR inhibitor, ARRY-768, in a rat model of gadolinium-induced fibrosis.
    Cox A, High W, Lee P, Allen S, Callejo M, Marmsater F, Munson M, Robinson J, Lyssikatos J, Yeh T, Kay J, Woessner R, Keystone Fibrosis Symposium, Keystone, CO
  • Golimumab significantly improves physical function & fatigue in RA patients previously treated with anti-TNFa agents: Results from the GO-AFTER study.
    Kay J, Doyle MK, Smolen J, Buchanan J, Matteson EL, Hsia EC, Landewé R, Zhou Y, Parasuraman S, Rahman MU, on behalf of the GO-LIVE Study Group, Ann Rheum Dis 2009; 68 (Suppl3):423
  • Efficacy and safety of oral imatinib mesylate in patients with nephrogenic systemic fibrosis.
    Kay, J, Sullivan ME, Patel TV, Arthritis Rheum 2009; 60 (Suppl 10):458
  • Join now to see all

Lectures

  • Seminar in Advanced Rheumatology and Board Review Course 
    NYU Langone Medical Center, New York, New York - 3/21/2013
  • Drug-Induced Lupus. 
    Arthritis Foundation, Massachusetts Chapter
  • Nonsteroidal Anti-inflammatory Drugs. 
    Hale Hospital, Haverhill, MA
  • Join now to see all

Other

Press Mentions

  • What Is the Criteria to Diagnose Rheumatoid Arthritis? What Patients Need to Know
    What Is the Criteria to Diagnose Rheumatoid Arthritis? What Patients Need to KnowOctober 15th, 2020
  • If You Have Rheumatoid Arthritis but Your Rheumatoid Factor Is Negative, What Does It Mean?
    If You Have Rheumatoid Arthritis but Your Rheumatoid Factor Is Negative, What Does It Mean?September 8th, 2020
  • ACR 2019: 50+ Arthritis Updates That Should Be on Your Radar
    ACR 2019: 50+ Arthritis Updates That Should Be on Your RadarNovember 24th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Jonathan Kay, Dr. Jonathan Kay, MD, Dr. J Kay